Market Overview

Actinium Pharmaceuticals Inc (NYSE: ATNM)

0.25 -0.00 (-0.08%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/12/18B. Riley FBRMaintainsBuy3.0
12/06/17B. Riley FBRInitiates Coverage OnBuy2.8
8/25/16Roth CapitalInitiates Coverage onBuy5.0
2/29/16H.C. WainwrightInitiates Coverage onBuy8.0
10/15/15FBR CapitalInitiates Coverage onOutperform12.0
10/01/14MLV & Co.Initiates Coverage onBuy16.0
7/22/14Canaccord GenuityInitiates Coverage onBuy16.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter